E. Kosmas (Voula/Athens, Greece), P. van der Valk (Enschede, Netherlands)
Characterization and effects of bronchial colonization and inflammation in stable COPD patients. PAC-COPD study
A. Marin-Tapia, J. García-Aymerich, E. Monsó, J. Sauleda, M. Garcia, F. Gómez, J. M. Antó, On Behalf of the PAC-COPD Study Group (Badalona, Barcelona, Palma Mallorca, Spain)
|   |
Resolution of isolated compared to recurrent COPD exacerbations
R. Baghai-Ravary, J. Quint, J. Goldring, J. Hurst, G. Donaldson, J. Wedzicha (London, United Kingdom)
| |
Associations of COPD severity and severity of exacerbation with sputum microbiologic profile and long-term survival
A. Tsimogianni, S. Papiris, S. Kanavaki, E. Manali, P. Michalopoulou, C. Sotiropoulou, C. Roussos, A. Kotanidou (Athens, Haidari, Athens, Greece)
| |
Subpopulation structure of lymphocytes in patients with chronic obstructive pulmonary disease (COPD) during exacerbation and after treatment
I. Tseimakh, T. Martynenko, P. Shpigotskaya (Barnaul, Russian Federation)
| |
The role of procalcitonin in the differential diagnosis and in the response to treatment of lower respiratory tract infections
M. Kalamanoglu, B. Ceyhan, S. Aydogan, T. Kuyucu, H. Altinoz (Istanbul, Turkey)
| |
Cytokine profile of blood and sputum at infectional COPD exacerbation
S. Nesterovich (Tomsk, Russian Federation)
| |
Sputum purulence guided antibiotic therapy in patients with exacerbations of COPD requiring hospitalization
N. Soler, M. Esperatti, C. Esquinas, E. Ballester, A. Torres (Barcelona, Spain)
| |
Composition of bronchial brush-biopsies in dependence on infectional agent species at COPD exacerbation
S. Nesterovich, E. Bukreeva (Tomsk, Russian Federation)
| |
Antibiotic prescribing practises of hospital doctors for COPD exacerbations
I. White, V. Dudzevicius, N. Krishnaraj, S. Murphy (Middlesbrough, Doncaster, United Kingdom)
| |
Are we over-prescribing antibiotics in acute hospital admissions for exacerbations of COPD?
S. Saha, W. Ahmed, C. Brook, T. Fernandez, S. Fong, P. Raines, A. Choudhury (London, Romford, United Kingdom)
| |
Management of chronic obstructive pulmonary disease (COPD) exacerbations: results of a French cohort study
C. Mayaud, S. Lignot, S. Lamarque, R. Lassalle, M. A. Bernard, J. L. Demeaux, D. Guillemot, B. Housset, D. Peyramond, D. Pouchain, P. Blin, N. Moore, M. Molimard (Paris, Bordeaux, Creteil, Lyon, Vincennes, France)
| |
Antibiotics in the exacerbations of severe and very severe chronic obstructive pulmonary disease (COPD)
A. Kosma, V. Dramba, G. Koundi, E. Markopoulou, E. Fouka, E. Kalaitzidou, N. Galanis (Thessaloniki, Greece)
| |
Pulsed moxifloxacin therapy and health status in patients with acute exacerbations of chronic obstructive pulmonary disease (the PULSE study)
P. Jones, T. Evers, D. Haverstock, S. Sethi (London, United Kingdom; Wuppertal, Germany; Connecticut, Buffalo, NY, United States Of America)
| |
Role of colonization on inflammation in COPD patients with bronchiectasis
M. Pappalettera, G. Migliara, A. Stefano, V. Popescu Janu, S. Dallari, B. Galbiati, L. Allegra (Milan, Italy)
| |
Bronchiectasis impact outcomes in patients with chronic obstructive pulmonary disease (COPD)
L. Ruvolo, M. Pappalettera, S. M. Donghi, G. Migliara, S. Aliberti, K. Dimakou, F. Blasi, L. Allegra (Milan, Italy; Athens, Greece)
| |
Sputum analysis and management of non-CF bronchiectasis in Singleton hospital
A. Dushianthan, S. Packham (Swansea, United Kingdom)
| |
Non-CF bronchiectasis: nebulised colistimethate sodium improves symptoms and bacterial load in sputum of patients with pseudomonas aeruginosa
K. Dimakou, K. Tsikritsaki, G. Hillas, M. Toumbis (Athens, Greece)
| |
Bacterial pathogens in sputum and pharyngeal specimens in elderly chronic lung disease patients
P. Torkko, A. Palmu, L. Erkkilä, A. Saukkoriipi, T. Kilpi, T. Pascal (Tampere, Oulu, Helsinki, Finland; Rixensart, Belgium)
| |
Non-cystic fibrosis bronchiectasis: series of 89 patients
T. M. Alfaro, C. Robalo Cordeiro, M. Loureiro, M. Fontes Baganha (Coimbra, Portugal)
| |
Stable non-cystic fibrosis bronchiectasis is associated with deficiency of the pattern recognition molecule L-Ficolin
J. Chalmers, S. MacDonald, A. Mohammed, M. Murray, S. Hart, D. Kilpatrick, A. Hill (Edinburgh, United Kingdom)
| |